Quest Diagnostics Q2 revenues $2.76B (+15.2%), beats; raises FY2025 adjusted EPS guidance to $9.63-$9.83

QUEST DIAGNOSTICS INC

2025-Q2 EPS reported $4.41 revenue$5,413,000,000

Q2 revenue $2.76B, up 15.2% YoY; organic revenue growth 5.2%.
Reported diluted EPS $2.47 (+21.7%); adjusted diluted EPS $2.62 (+11.5%).
Cash from operations $544M in Q2 (+51.5%); YTD $858M (+67.1%).
Raises full-year 2025 net revenue guidance to $10.80B-$10.92B (from $10.70B-$10.85B).
FY2025 adjusted diluted EPS guidance raised to $9.63-$9.83 from $9.55-$9.80.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.